View in EDS HTML Full Text PDF Full Text

Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
Authors: Xu, XueYin1 (AUTHOR), Tang, Lian1 (AUTHOR), Piao, XiangHua2 (AUTHOR), Zhan, ShaoQing1 (AUTHOR), Chen, Yong1 (AUTHOR) chenyong20242024@126.com, Feng, PanFeng1,3,4 (AUTHOR) 929083891@qq.com
Source: PLoS ONE. 5/14/2026, Vol. 21 Issue 5, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 193757134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Xu%2C+XueYin%22">Xu, XueYin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Lian%22">Tang, Lian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piao%2C+XiangHua%22">Piao, XiangHua</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhan%2C+ShaoQing%22">Zhan, ShaoQing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Yong%22">Chen, Yong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> chenyong20242024@126.com</i><br /><searchLink fieldCode="AR" term="%22Feng%2C+PanFeng%22">Feng, PanFeng</searchLink><relatesTo>1,3,4</relatesTo> (AUTHOR)<i> 929083891@qq.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 5/14/2026, Vol. 21 Issue 5, p1-13. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193757134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0349044
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1
    Titles:
      – TitleFull: Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu, XueYin
      – PersonEntity:
          Name:
            NameFull: Tang, Lian
      – PersonEntity:
          Name:
            NameFull: Piao, XiangHua
      – PersonEntity:
          Name:
            NameFull: Zhan, ShaoQing
      – PersonEntity:
          Name:
            NameFull: Chen, Yong
      – PersonEntity:
          Name:
            NameFull: Feng, PanFeng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 05
              Text: 5/14/2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1